Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

BACKGROUND & AIMS: Therapeutic drug monitoring (TDM) is widely available for biologic therapies in patients with inflammatory bowel disease (IBD). We reviewed current data and provided expert opinion regarding the clinical utility of TDM for biologic therapies in IBD. METHODS: We used a modified...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Gastroenterol Hepatol
Autores principales: Papamichael, Konstantinos, Cheifetz, Adam S., Melmed, Gil Y., Irving, Peter M., Casteele, Niels Vande, Kozuch, Patricia L., Raffals, Laura E., Baidoo, Leonard, Bressler, Brian, Devlin, Shane M., Jones, Jennifer, Kaplan, Gilaad G., Sparrow, Miles P., Velayos, Fernando S., Ullman, Thomas, Siegel, Corey A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6661210/
https://ncbi.nlm.nih.gov/pubmed/30928454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2019.03.037
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares